{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T03:58:28Z","timestamp":1783051108207,"version":"3.54.6"},"reference-count":30,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Clinical Electrophysiology"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.jacep.2017.02.016","type":"journal-article","created":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T09:17:58Z","timestamp":1496308678000},"page":"1158-1167","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"title":["Antibacterial Envelope Is Associated With\u00a0Low Infection Rates After Implantable Cardioverter-Defibrillator and\u00a0Cardiac Resynchronization Therapy Device Replacement"],"prefix":"10.1016","volume":"3","author":[{"given":"Charles A.","family":"Henrikson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Rizwan","family":"Sohail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helbert","family":"Acosta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric E.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Rosenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman","family":"Pachulski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Dan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Paladino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhat S.","family":"Khairallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kent","family":"Gleed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Hanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel R.","family":"Lexcen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grant R.","family":"Simons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacep.2017.02.016_bib1","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.hrthm.2010.05.016","article-title":"Cardiac implantable electronic device infections: Presentation, management, and patient outcomes","volume":"7","author":"Tarakji","year":"2010","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacep.2017.02.016_bib2","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1001\/archinternmed.2011.441","article-title":"Mortality and cost associated with cardiovascular implantable electronic device infections","volume":"171","author":"Sohail","year":"2011","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacep.2017.02.016_bib3","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.hrthm.2011.10.034","article-title":"Cardiac device infections are associated with a significant mortality risk","volume":"9","author":"de Bie","year":"2012","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacep.2017.02.016_bib4","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1161\/01.CIR.97.18.1796","article-title":"Antibiotic prophylaxis for permanent pacemaker implantation: a meta-analysis","volume":"97","author":"Da Costa","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2017.02.016_bib5","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1161\/CIRCEP.108.795906","article-title":"Efficacy of antibiotic prophylaxis before the implantation of pacemakers and cardioverter-defibrillators: results of a large, prospective, randomized, double-blinded, placebo-controlled trial","volume":"2","author":"de Oliveira","year":"2009","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacep.2017.02.016_bib6","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.ahj.2003.06.005","article-title":"Increasing rates of cardiac device infections among Medicare beneficiaries: 1990-1999","volume":"147","author":"Cabell","year":"2004","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacep.2017.02.016_bib7","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.jacc.2006.05.016","article-title":"Rising rates of cardiac rhythm management device infections in the United States: 1996 through 2003","volume":"48","author":"Voigt","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacep.2017.02.016_bib8","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.1540-8159.2009.02569.x","article-title":"Continued rise in rates of cardiovascular implantable electronic device infections in the United States: temporal trends and causative insights","volume":"33","author":"Voigt","year":"2010","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.jacep.2017.02.016_bib9","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.jacc.2011.04.033","article-title":"16-year trends in the infection burden for pacemakers and implantable cardioverter-defibrillators in the United States 1993 to 2008","volume":"58","author":"Greenspon","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacep.2017.02.016_bib10","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1540-8159.2010.02931.x","article-title":"Implantation success and infection in cardiovascular implantable electronic device procedures utilizing an antibacterial envelope","volume":"34","author":"Bloom","year":"2011","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.jacep.2017.02.016_bib11","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/pace.12063","article-title":"Use of\u00a0an antibacterial envelope is associated with reduced cardiac implantable electronic device infections in high-risk patients","volume":"36","author":"Kolek","year":"2013","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.jacep.2017.02.016_bib12","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.hrthm.2013.12.013","article-title":"Cardiac implantable electronic device infections: incidence, risk factors, and the effect of the AigisRx antibacterial envelope","volume":"11","author":"Mittal","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacep.2017.02.016_bib13","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1016\/j.hrthm.2008.09.020","article-title":"Outcome of advisory implantable cardioverter-defibrillator replacement: one-year follow-up","volume":"5","author":"Gould","year":"2008","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacep.2017.02.016_bib14","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/europace\/euv053","article-title":"Risk factors for cardiac implantable electronic device infection: a systematic review and meta-analysis","volume":"17","author":"Polyzos","year":"2015","journal-title":"EuroPace"},{"key":"10.1016\/j.jacep.2017.02.016_bib15","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1086\/518889","article-title":"Risk factor analysis of permanent pacemaker infection","volume":"45","author":"Sohail","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jacep.2017.02.016_bib16","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1086\/501620","article-title":"Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee","volume":"20","author":"Mangram","year":"1999","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.jacep.2017.02.016_bib17","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/0002-9343(94)90143-0","article-title":"New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service","volume":"96","author":"Durack","year":"1994","journal-title":"Am J Med"},{"key":"10.1016\/j.jacep.2017.02.016_bib18","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1093\/biomet\/26.4.404","article-title":"The use of confidence or fiducial limits illustrated in the case of the binomial","author":"Clopper","year":"1934","journal-title":"Biometrika"},{"key":"10.1016\/j.jacep.2017.02.016_bib19","series-title":"Propensity score analysis: statistical methods and applications","author":"Guo","year":"2014"},{"key":"10.1016\/j.jacep.2017.02.016_bib20","series-title":"Econometric analysis of cross section and panel data","author":"Wooldridge","year":"2010"},{"key":"10.1016\/j.jacep.2017.02.016_bib21","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1136\/hrt.2008.151985","article-title":"Risk factors and time delay associated with cardiac device infections: Leiden device registry","volume":"95","author":"Lekkerkerker","year":"2009","journal-title":"Heart"},{"key":"10.1016\/j.jacep.2017.02.016_bib22","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.acvd.2011.02.003","article-title":"Cardiac\u00a0implantable devices: surveillance of surgical site infections and assessment of professional practices","volume":"104","author":"Metais","year":"2011","journal-title":"Arch Cardiovasc Dis"},{"key":"10.1016\/j.jacep.2017.02.016_bib23","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/eurheartj\/ehp421","article-title":"Prevalence and risk factors related to infections of cardiac resynchronization therapy devices","volume":"31","author":"Romeyer-Bouchard","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacep.2017.02.016_bib24","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.hrthm.2013.12.013","article-title":"Cardiac Implantable electronic device infections: incidence, risk factors, and the impact of the AigisRx antibacterial envelope","volume":"11","author":"Mittal","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacep.2017.02.016_bib25","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/jce.12684","article-title":"Health and economic outcomes associated with use of an antimicrobial envelope as a standard of care for cardiac implantable electronic device implantation","volume":"26","author":"Shariff","year":"2015","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacep.2017.02.016_bib26","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1001\/jama.295.16.1907","article-title":"Complications associated with implantable cardioverter-defibrillator replacement in response to device advisories","volume":"295","author":"Gould","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.jacep.2017.02.016_bib27","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1161\/CIRCEP.110.959791","article-title":"Predictors of short-term complications after implantable cardioverter-defibrillator replacement: results from the Ontario ICD database","volume":"4","author":"Krahn","year":"2011","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacep.2017.02.016_bib28","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1161\/CIRCOUTCOMES.111.000054","article-title":"Characteristics and outcomes of patients receiving new and replacement implantable cardioverter-defibrillators: results from the NCDR","volume":"6","author":"Kramer","year":"2013","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacep.2017.02.016_bib29","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1540-8159.2011.03257.x","article-title":"Cardiovascular implantable electronic device replacement infections and prevention: results from the REPLACE Registry","volume":"35","author":"Uslan","year":"2012","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.jacep.2017.02.016_bib30","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1161\/CIRCULATIONAHA.114.009081","article-title":"Rates\u00a0of and factors associated with infection in 200,909 Medicare implantable cardioverter-defibrillator implants: results from the NCDR\u00ae","volume":"130","author":"Prutkin","year":"2014","journal-title":"Circulation"}],"container-title":["JACC: Clinical Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405500X17302505?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405500X17302505?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T07:24:37Z","timestamp":1762500277000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405500X17302505"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":30,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S2405500X17302505"],"URL":"https:\/\/doi.org\/10.1016\/j.jacep.2017.02.016","relation":{},"ISSN":["2405-500X"],"issn-type":[{"value":"2405-500X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antibacterial Envelope Is Associated With\u00a0Low Infection Rates After Implantable Cardioverter-Defibrillator and\u00a0Cardiac Resynchronization Therapy Device Replacement","name":"articletitle","label":"Article Title"},{"value":"JACC: Clinical Electrophysiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacep.2017.02.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}